A new trading day began on Friday, with Repare Therapeutics Inc (NASDAQ: RPTX) stock price remained unchanged from the previous day of trading, before settling in for the closing price of $1.28. RPTX’s price has ranged from $1.20 to $8.49 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 1775.76%. Meanwhile, its annual earnings per share averaged 3.89%. With a float of $30.02 million, this company’s outstanding shares have now reached $42.51 million.
Let’s determine the extent of company efficiency that accounts for 179 employees. In terms of profitability, gross margin is 97.75%, operating margin of -139.9%, and the pretax margin is -122.88%.
Repare Therapeutics Inc (RPTX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Repare Therapeutics Inc is 29.39%, while institutional ownership is 45.04%. The most recent insider transaction that took place on Mar 28 ’24, was worth 12,243. In this transaction PRESIDENT AND CEO of this company sold 2,650 shares at a rate of $4.62, taking the stock ownership to the 110,049 shares. Before that another transaction happened on Apr 01 ’24, when Company’s PRESIDENT AND CEO sold 2,491 for $4.63, making the entire transaction worth $11,533. This insider now owns 107,558 shares in total.
Repare Therapeutics Inc (RPTX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.72 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 3.89% per share during the next fiscal year.
Repare Therapeutics Inc (NASDAQ: RPTX) Trading Performance Indicators
Here are Repare Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 6.45. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.82.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.00, a number that is poised to hit -0.83 in the next quarter and is forecasted to reach -2.69 in one year’s time.
Technical Analysis of Repare Therapeutics Inc (RPTX)
Looking closely at Repare Therapeutics Inc (NASDAQ: RPTX), its last 5-days average volume was 0.33 million, which is a drop from its year-to-date volume of 0.5 million. As of the previous 9 days, the stock’s Stochastic %D was 20.00%. Additionally, its Average True Range was 0.18.
During the past 100 days, Repare Therapeutics Inc’s (RPTX) raw stochastic average was set at 2.79%, which indicates a significant decrease from 28.57% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.17% in the past 14 days, which was lower than the 150.76% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.3771, while its 200-day Moving Average is $3.1574. However, in the short run, Repare Therapeutics Inc’s stock first resistance to watch stands at $1.2966. Second resistance stands at $1.3132. The third major resistance level sits at $1.3315. If the price goes on to break the first support level at $1.2617, it is likely to go to the next support level at $1.2434. Should the price break the second support level, the third support level stands at $1.2268.
Repare Therapeutics Inc (NASDAQ: RPTX) Key Stats
With a market capitalization of 54.41 million, the company has a total of 42,511K Shares Outstanding. Currently, annual sales are 51,130 K while annual income is -93,800 K. The company’s previous quarter sales were 1,070 K while its latest quarter income was -34,770 K.
